Publications by authors named "Rory Chan"

Claim this Profile
R
Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
Fraser Paterson, Jing Yuan On, Dania Ahmed, Remo Poto, Atanu Bhattacharjee, Rory Chan

Ann Allergy Asthma Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships of type 2 biomarkers with spirometry in response to tezepelumab in uncontrolled severe asthma.
Robert Greig, Philipp Suter, Rory Chan, Brian Lipworth

J Allergy Clin Immunol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond the asthma guidelines: look under the hood, particularly in those considered well controlled.
Vincent Hussey, Marcello Cottini, Rory Chan, Stanley P Galant

Ann Allergy Asthma Immunol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on oscillometry in asthma.
Francesco Menzella, Rory Chan, Carlo Lombardi, Alvise Berti, Marcello Cottini

Expert Rev Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of dupilumab and mepolizumab in eosinophilic COPD: insights from phase 3 trials.
Philipp Suter, Robert Greig, Rory Chan, Brian Lipworth

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of oscillometry ratios between IOS and AOS in patients with asthma and COPD.
Philipp Suter, Robert Greig, Chris RuiWen Kuo, Rory Chan, Brian Lipworth

Respir Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the obesity-asthma link: A new horizon with glucagon-like peptide-1 receptor agonists in a complex intersection of metabolism and airway disease.
Francesco Menzella, Marcello Cottini, Rory Chan

J Int Med Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab for severe asthma - an "all round" player.
Ophir Freund, Hitasha Rupani, Brian Lipworth, Rory Chan

Eur J Intern Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small Airway Dysfunction Is an Independent Exacerbation Risk Biomarker in the Mild, Well-Controlled Patient With Asthma: A Frequently Unrecognized High-Risk Phenotype.
Stanley P Galant, Marcello Cottini, Alvise Berti, Pasquale Comberiati, Carlo Lombardi, Rory Chan

J Allergy Clin Immunol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 biomarkers and airway hyper-responsiveness disconnect in patients with uncontrolled severe asthma taking benralizumab or dupilumab.
Robert Greig, Rory Chan, Brian Lipworth

Ann Allergy Asthma Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body mass index and lung function decline in persistent asthma.
Rory Chan, Marcello Cottini, Francesco Menzella, Remo Poto, Zuzana Diamant

Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of dupilumab on oscillometry and spirometry derived ratios in severe refractory asthma.
Robert Greig, Philipp Suter, Rory Chan, Brian Lipworth

Respir Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reappraisal of Biologic Efficacy from Phase 3 Trials in Refractory Chronic Rhinosinusitis and Nasal Polyps.
Brian J Lipworth, Robert Greig, Rory Chan, Chris RuiWen Kuo

J Allergy Clin Immunol Pract· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the preserved ratio impaired spirometry phenotype in all severities of asthma.
Marcello Cottini, Remo Poto, Atanu Bhattacharjee, Stanley Galant, Brian Lipworth, Rory Chan

Respir Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing precision medicine for asthma by focusing on type 2 cytokines and alarmins.
Remo Poto, Andrea Portacci, Rory Chan, Gianluca Lagnese, Mattia Giovannini

Curr Opin Allergy Clin Immunol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-Life Indirect Case Matched Comparison of Dupilumab and Tezepelumab on Airway Oscillometry.
Robert Greig, Rory Chan, Brian Lipworth

Allergy· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Worse airflow obstruction but not type 2 biomarkers identifies super-responders to tezepelumab in real life.
Robert Greig, Rory Chan, Brian J Lipworth

Ann Allergy Asthma Immunol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A real-world study on tezepelumab effectiveness in severe asthma focusing on small airway dysfunction.
Francesco Menzella, Marcello Cottini, Carlo Lombardi, Gianenrico Senna, Rory Chan

Respir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Head-To-Head Comparison of Biologic Efficacy in Asthma: What Have We Learned?
Brian J Lipworth, Robert Greig, Rory Chan, Chris RuiWen Kuo, Catherine Jackson

Allergy· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oscillometry and spirometry derived ratios to assess small airways dysfunction in severe asthma patients taking tezepelumab.
Robert Greig, Rory Chan, Brian Lipworth

Respir Med· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucus Plugging as a Prognostic Indicator for Biologic Treatment Response in Severe Asthma.
Rory Chan, Brian Lipworth, Marcello Cottini, Robert Greig, Remo Poto

J Allergy Clin Immunol Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' response.
Rory Chan, Carlo Lombardi, Pasquale Comberiati, Alvise Berti, Francesco Menzella

Ann Allergy Asthma Immunol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship Between Bronchodilator Reversibility and Spirometry Response to Dupilumab in Type 2 High Uncontrolled Severe Asthma.
Robert Greig, Kirsten Stewart, Chris RuiWen Kuo, Rory Chan, Brian Lipworth

Clin Exp Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of Small Airways Dysfunction With Dupilumab Using Airway Oscillometry in Uncontrolled Severe Asthma.
Kirsten E Stewart, Chris RuiWen Kuo, Rory Chan, Brian J Lipworth

Clin Exp Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in Small Airway Physiology Measured by Impulse Oscillometry in Subjects with Allergic Asthma Following Methacholine and Inhaled Allergen Challenge.
Henning Stenberg, Rory Chan, Khalid Abd-Elaziz, Arjen Pelgröm, Karin Lammering

J Clin Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis